WORLD TRADE  
ORGANIZATION  G/TBT/N/EEC/196 
29 May 2008 
 (08-2506) 
Committee on Technical Barriers to Trade Original:   English 
  
 
 
NOTIFICATION 
 
The following notification is being circ ulated in accordance with Article 10.6. 
 
1. Member to Agreement notifying:   EUROPEAN COMMUNITIES
 
If applicable, name of local government involved (Articles 3.2 and 7.2):         
2. Agency responsible:   European Commission 
Name and address (including telephone and fax numbers, e-mail and web-site 
addresses, if available) of  agency or authority designated to handle comments 
regarding the notification shall be  indicated if different from above:    
European Commission 
EC-TBT Enquiry Point Fax:  +(32) 2299 8043 Email:  ec-tbt@ec.europa.eu
 
Website: http://ec.europa.eu/enterprise/tbt/  
3. Notified under Article 2.9.2 [  X ], 2.10.1 [   ], 5.6.2 [   ], 5.7.1 [   ], other:         
4. Products covered (HS or CCCN where applicable, otherwise national tariff heading. 
ICS numbers may be provided in  addition, where applicable):   Beauveria brogniartii 
and potassium permanganate, buprofezin, butra lin, cyanamide, dichlobenil, dicloran, 
dicofol, diniconazole, methyl bromide, prop achlor, propanil, tricyclazole, triflumizole 
(pesticide active substances). 
5. Title, number of pages and language(s) of the notified document:   Draft Commission 
Decisions concerning the non-inclusion of [respectively] beauveria brogniartii and potassium permanganate, buprofezin, butralin, cy anamide, dichlobenil, dicloran, dicofol, 
diniconazole, methyl bromide, propachlor, propan il, tricyclazole, triflumizole, in Annex I to 
Council Directive 91/414/EEC and the withdrawal  of authorisations for plant protection 
products containing these substances (5 pages (for each draft decision), in English). 
6. Description of content:   The drafts provide that respectively beauveria brogniartii and 
potassium permanganate, buprofezin, butralin, cy anamide, dichlobenil, dicloran, dicofol, 
diniconazole, methyl bromide, propachlor, pr opanil, tricyclazole, triflumizole, are not 
included in the positive Community list and that Member States have to withdraw 
authorisations for plant protection products containing these substances. These draft decisions only concern the placing on the market  of these substances and do not affect the 
Community or national Maximum Residue Leve ls (MRLs) for residues of the concerned 
pesticides. G/TBT/N/EEC/196 
Page 2  
 
  7. Objective and rationale, including the na ture of urgent problems where applicable:  
Directive 91/414/EEC concerning the placing of plant protection products on the market 
sets up a harmonised framework for the authorisation and placing on the market of plant protection products in order to protect  human health and the environment. 
Article 8(2) of this Directive provides for a programme to be carried out over a period of 
12 years for the gradual examination of th e active substances contained in the plant 
protection products on the market. Substances fo r which the outcome of the evaluation is 
favourable are then included in Annex I of the Directive. 
Buprofezin, butralin, cyanamide, dichlobenil, dicloran, dicofol, diniconazole, methyl 
bromide, propachlor, propanil, tricyclazole a nd triflumizole, are substances covered by the 
third stage of this work programme. 
Beauveria brogniartii and potassium permanganate we re included in the fourth stage of this 
work programme, according to the provisions of Regulation (EC) No 2229/2004. Before the 
evaluation of the submitted dossiers was finalised , all notifiers withdrew their participation 
in the programme of work. 
- During the evaluation of buprofezin, a number of  concerns were identified. In particular it 
was not possible to perform a reliable consumer exposure assessment as data are missing to determine an appropriate residue definition. Consequently, it was not possible to conclude on the basis of the information available that bupr ofezin met the criteria for inclusion in Annex 
I to Directive 91/414/EEC.  
- During the examination of butralin, cyanamide, diniconazole and propanil by the 
Committee, taking into account comments received from Member States, it was concluded 
that there are clear indications that it may be  expected that they have harmful effects on 
human health and in particular on operators b ecause exposure is greater than 100 % of the 
AOEL. 
- During the examination of dicofol by the Committee, taking into account comments 
received from Member States, it was concluded that there are clear indications that it may be expected that it has harmful effects on human health and in particular on both operators and workers, because the e xposure is greater than 100% of th e AOEL.  Furthermore, there are 
data gaps in the consumer risk assessment. 
- During the examination of dichlobenil by  the Committee, taking into account comments 
from Member States, it was concluded that there are clear indications that it may be expected that it has harmful effects on human health and in particular on consumers from drinking water because exposure is greater than  100% of the ADI of a relevant metabolite and 
leaching to groundwater is above 0,1 μg/l in all modeled scenarios for this relevant metabolite. 
- During the examination of dicloran by  the Committee, taking into account comments 
received from Member States, it was concluded that there are clear indications that it may 
be expected that it has harmful effects on human health and in particular on workers because exposure is greater than 100 % of the AOEL. 
- During the examination of methyl brom ide by the Committee, taking into account 
comments from Member States, it was concluded that there are clear indications that it may be expected that it has harmful effects on human health and in particular on bystanders 
because exposure is greater than 100% of the AOEL and on consumers because exposure is 
greater than 100% of the ADI and the ARfD.  G/TBT/N/EEC/196 
 Page 3 
 
 
  - During the examination of propachlor by the Committee, taking into account comments 
received from Member States, it was concluded that there are clear indications that it may be expected that it has harmful effects on groundwater and in particular the leaching to groundwater is above 0,1 μg/l in all modeled scenarios for three relevant metabolites. 
- During the examination of tricyclazole by the Committee, taking into account comments 
received from Member States, it was concluded that there are clear indications that it may 
be expected that it has harmful effects on human health and in particular the crucial missing 
data does not allow for the setting of reliabl e ADI, ARfD and AOEL and such values are 
necessary to conduct th e risk assessment. 
- During the examination of triflumizole by  the Committee, taking into account comments 
from Member States, it was concluded that there are clear indications that it may be 
expected that it has harmful effects on human health and in particular on operators and 
workers because  exposure is greater than 100 % of the AOEL. 
A period of grace for disposal, storage, placing on the market and use of existing stocks of 
plant protection products containing beauveria brogniartii and potassium permanganate, 
buprofezin, butralin, cyanamide, dichlobenil, dicloran, dicofol, diniconazole, methyl 
bromide, propachlor, propanil, tricyclazole, triflumizole, allowed by a Member State, in accordance with the provisions of  Article 4(6) of Directive 91/41 4/EEC, is limited to a period 
not longer than 12 months, i.e. 18 months from the date of adoption of the Commission decisions. 
8. Relevant documents:   Council Directive 91/414/EEC of 15 July 1991 concerning the placing 
of plant protection products on the market, OJ L 230, 19.8.1991, p. 1. 
http://eur-
lex.europa.eu/LexUriServ/LexUriServ. do?uri=CONSLEG:1991L0 414:20070201:EN:PDF  
9. Proposed date of adoption:   
 
Proposed date of entry into force:    15 October 2008 (July 2008 for beauveria 
brogniartii and potassium permanganate) 
Member States have to withdraw all existing 
authorizations for plant protection products containing those active substances 6 months 
after the date of adoption. 
10. Final date for comments:   60 days from date of notification G/TBT/N/EEC/196 
Page 4  
 
  11. Texts available from:  National enquiry point [    ] or address, telephone and fax 
numbers, e-mail and web-site addresses, if available of the other body:   
European Commission 
EC-TBT Enquiry Point Fax:  + (32) 2299 8043 
E-mail:  ec-tbt@ec.europa.eu
 
The texts are available on the EC-TBT Website: http://ec.europa.eu/enterprise/tbt/  
and also at:  http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_00_e.pdf
 
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_01_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_02_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_03_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_04_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_05_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_06_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_07_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_08_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_09_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_10_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_11_e.pdf  
http://members.wto.org/crnattachments/2008/tbt/eec/08_1538_12_e.pdf